For example, activated FAK/Syk/Akt/mTOR and STAT3 pathways are known to underlie Reelin-driven cancer cell growth and metabolic reprogramming, including glycolysis in myeloma cells [23]. This evidence concerns the gene PTK2 and plasma cell myeloma.